Shares of Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) rose sharply in today’s pre-market trading session. Titan Pharmaceuticals said its Board of Directors has approved a 1-for-20 reverse stock split. Titan Pharmaceuticals shares jumped 15.2% to $0.38 in pre-market trading.